1Cooper DS. Hyperthyroidism. Lancet, 2003,362 : 459-468.
2American College of Obstetrics and Gynecology. ACOG practice bulletin. Thyroid disease in pregnancy. Number 37, August 2002.American College of Obstetrics and Gynecology. Int J Gynaecol Obstet ,2002,79 : 171-180.
3Omotani N, Ito K, Hamada N, et al. Maternal hyperthyroidism and congenital malformation in the offspring. Clin Endocrinol, 1984,20 :695-700.
4Wing DA, Millar LK, Koonings PP, et al. A comparison of propylthiouracil versus methimazole in the treatment of hyperthyroidism in pregnancy. Am J Obstet Gynecol, 1994,170:90-95.
5Clementi M, Di Gianantonio E, Pelo E, et al. Methimazole embryopathy: delineation of the phenotype. Am J Med Genet, 1999,83:43-46.
6Martinez-Frias ML, Cereijo A, Rodriguez-Pinilla E, et al.Methimazole in the animal feed and congenital aplasis cutis. Lancet,1992, 339:742-743.
7Mandel SJ, Cooper DS. The use of antithyroid drugs in pregnancy and lactation. J Clin Endocrinol Metab, 2001,86:2354-2359.
8Diez-Delgado R j, Belmonte- Martin M J, Calvo-Bonachera MD, et al. Aplasia cutis as a teratogentic effect of methimazole. An Esp Pediatr, 1999,51 : 290-292.
9Wilson LC, Kerr BA, Wilkinson R, et al. Choanal atresia and hypothelia following methimazole exposure in utero: a second report. Am J Med Genet, 1998,75:220-222.
10Seoud M, Nassar A, Usta I, et aL Gastrointestinal malformations in two infants born to women with hyperthyroidism untreated in the first trimester. Am J Perinatol, 2003,20:59-62.
